Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination

Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination

US Patent 6509348 · Granted Jan 21, 2003

Estimated economic value: $117,608,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating dysmenorrhea employing an interphenylene 7-oxabicycloheptyl s1997
Method of protecting against and/or treating ulcerative gastrointestinal conditi1994
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal condi1993
7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs1992
Method of preventing or reducing adverse reactions to protamine using a thrombox1991
Method of inhibiting onset of or treating migraine headache using a thromboxane 1989
Method of preventing or treating toxemia in pregnancy using a thromboxane A.sub.1989